APOBEC3A and cancer: Low pre-treatment levels of APOBEC3A have been reported previously, and expression of both APOBEC3B and APOBEC3A has been reported to increase in response to cancer cell treatment with DNA-damaging agents or as part of cellular interferon-induced transcriptional response to viral infections [7].